Molecular mr imaging of prostate cancer

Avan Kader; Julia Brangsch; Jan O. Kaufmann; Jing Zhao; Dilyana B. Mangarova; Jana Moeckel; Lisa C. Adams; Ingolf Sack; Matthias Taupitz; Bernd Hamm; Marcus R. Makowski

doi:10.3390/biomedicines9010001

Molecular mr imaging of prostate cancer

Avan Kader, Julia Brangsch, Jan O. Kaufmann, Jing Zhao, Dilyana B. Mangarova, Jana Moeckel, Lisa C. Adams, Ingolf Sack, Matthias Taupitz, Bernd Hamm, Marcus R. Makowski

Chair of Radiology

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Abstract

This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa could improve the molecular characterization of the tumor in a non-invasive examination. Furthermore, molecular probes could enable targeted therapies to suppress tumor growth or reduce the tumor size.

Original language	English
Article number	1
Pages (from-to)	1-17
Number of pages	17
Journal	Biomedicines
Volume	9
Issue number	1
DOIs	https://doi.org/10.3390/biomedicines9010001
State	Published - Dec 2021

Keywords

Magnetic resonance imaging
Molecular imaging
Molecular marker
Prostate cancer

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/biomedicines9010001

Cite this

@article{509c2b19ab584b3792febe261a3be426,

title = "Molecular mr imaging of prostate cancer",

abstract = "This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa could improve the molecular characterization of the tumor in a non-invasive examination. Furthermore, molecular probes could enable targeted therapies to suppress tumor growth or reduce the tumor size.",

keywords = "Magnetic resonance imaging, Molecular imaging, Molecular marker, Prostate cancer",

author = "Avan Kader and Julia Brangsch and Kaufmann, {Jan O.} and Jing Zhao and Mangarova, {Dilyana B.} and Jana Moeckel and Adams, {Lisa C.} and Ingolf Sack and Matthias Taupitz and Bernd Hamm and Makowski, {Marcus R.}",

note = "Publisher Copyright: {\textcopyright} 2020 by the authors. Li-censee MDPI, Basel, Switzerland.",

year = "2021",

month = dec,

doi = "10.3390/biomedicines9010001",

language = "English",

volume = "9",

pages = "1--17",

journal = "Biomedicines",

issn = "2227-9059",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "1",

}

TY - JOUR

T1 - Molecular mr imaging of prostate cancer

AU - Kader, Avan

AU - Brangsch, Julia

AU - Kaufmann, Jan O.

AU - Zhao, Jing

AU - Mangarova, Dilyana B.

AU - Moeckel, Jana

AU - Adams, Lisa C.

AU - Sack, Ingolf

AU - Taupitz, Matthias

AU - Hamm, Bernd

AU - Makowski, Marcus R.

PY - 2021/12

Y1 - 2021/12

N2 - This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa could improve the molecular characterization of the tumor in a non-invasive examination. Furthermore, molecular probes could enable targeted therapies to suppress tumor growth or reduce the tumor size.

AB - This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa could improve the molecular characterization of the tumor in a non-invasive examination. Furthermore, molecular probes could enable targeted therapies to suppress tumor growth or reduce the tumor size.

KW - Magnetic resonance imaging

KW - Molecular imaging

KW - Molecular marker

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85098848168&partnerID=8YFLogxK

U2 - 10.3390/biomedicines9010001

DO - 10.3390/biomedicines9010001

M3 - Review article

AN - SCOPUS:85098848168

SN - 2227-9059

VL - 9

SP - 1

EP - 17

JO - Biomedicines

JF - Biomedicines

IS - 1

M1 - 1

ER -

Molecular mr imaging of prostate cancer

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this